Chemical Compound

(alphaR,betaR)-beta-(Cyclopentylmethyl)-N-hydroxy-gamma-oxo-alpha-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl]-1-piperidinebutanamide; Cipemastat; Ro 32-3555/000; Trocade; Ro 32-3555

CAS Registry Number 190648-49-8
(alphaR,betaR)-beta-(Cyclopentylmethyl)-N-hydroxy-gamma-oxo-alpha-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl]-1-piperidinebutanamide; Cipemastat; Ro 32-3555/000; Trocade; Ro 32-3555 结构式
Primary record

(alphaR,betaR)-beta-(Cyclopentylmethyl)-N-hydroxy-gamma-oxo-alpha-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl]-1-piperidinebutanamide; Cipemastat; Ro 32-3555/000; Trocade; Ro 32-3555

库存
5,702 克
纯度
99.4 %
CAS
190648-49-8

化合物标识与属性

CAS
190648-49-8
PubChem CID
9824350
SMILES
CC1(C(=O)N(C(=O)N1C)C[C@@H]([C@@H](CC2CCCC2)C(=O)N3CCCCC3)C(=O)NO)C
Canonical SMILES
CN1C(=O)N(C[C@H](C(=O)NO)[C@@H](CC2CCCC2)C(=O)N2CCCCC2)C(=O)C1(C)C

名称与同义词

  • Cipemastat
  • Trocade
  • cipemastatum
  • 190648-49-8
  • Ro 32-3555
  • Trocade (TN)
  • Cipemastat [USAN:INN]
  • CIPEMASTAT [INN]
  • Cipemastat (USAN/INN)
  • 02HQ4TYQ60
  • CIPEMASTAT [USAN]
  • UNII-02HQ4TYQ60
  • RefChem:1100558
  • D0MW3H
  • CIPEMASTAT [WHO-DD]
  • DTXSID10897569
  • GFUITADOEPNRML-SJORKVTESA-N
  • C22H36N4O5
  • CHEMBL115653
  • GTPL6466
  • orb1710047
  • SCHEMBL7088217
  • BDBM30344
  • CTK8F1312
  • Ro 32-3555/000
  • DTXCID001326916
  • GLXC-01794
  • ZINC600699
  • Ro-32-03555
  • EX-A9430
  • Ro-323555000
  • MFCD00944012
  • Ro-32-3555
  • AKOS024457333
  • C22-H36-N4-O5
  • CID9824350
  • Ro 28-2653
  • HY-19677
  • MS-27825
  • RO-32-3555/000
  • J846.779J
  • RO32-3555
  • RT-015421
  • A4439
  • CS-0016192
  • A15311
  • D03517
  • G12916
  • (2R,3R)-3-(cyclopentylmethyl)-N-hydroxy-4-oxo-4-piperidin-1-yl-2-[(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl]butanamide
  • A1244876
  • Q3885848
  • BRD-K95362002-001-01-1
  • 1-Piperidinebutanamide, beta-(cyclopentylmethyl)-N-hydroxy-gamma-oxo-alpha-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl]-, (alphaR,betaR)-
  • (2R,3R)-3-(cyclopentylmethyl)-N-hydroxy-4-oxo-4-(piperidin-1-yl)-2-((3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl)butanamide
  • (?R,?R)-?-(Cyclopentylmethyl)-N-hydroxy-?-oxo-?-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl]-1-piperidinebutanamide
  • (2R,3R)-2-[(2,5-Dioxo-3,4,4-trimethylimidazolidine-1-yl)methyl]-3-(piperidinocarbonyl)-4-cyclopentylbutanehydroximic acid
  • (2R,3R)-3-(cyclopentylmethyl)-4-oxo-4-(1-piperidyl)-2-[(3,4,4-trimethyl-2,5-dioxo-imidazolidin-1-yl)methyl]butanehydroxamic acid
  • (2R,3R)-3-(Cyclopentylmethyl)-N-hydroxy-4-oxo-4-(piperidin-1-yl)-2-[(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl]butanamide
  • (2R,3R)-3-(cyclopentylmethyl)-N-hydroxy-4-oxo-4-piperidin-1-yl-2-((3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl)butanamide
  • (2R,3R)-N-Hydroxy-2-(2,5-dioxo-3,4,4-trimethylimidazolidine-1-ylmethyl)-3-(cyclopentylmethyl)-4-oxo-4-piperidinobutyramide
  • (alphaR,betaR)-beta-(Cyclopentylmethyl)-gamma-oxo-alpha-((3,4,4-piperidinebutyrohydroxamic acid
  • (alphaR,betaR)-beta-(Cyclopentylmethyl)-gamma-oxo-alpha-[(3,4,4-piperidinebutyrohydroxamic acid
  • (alphaR,betaR)-beta-(Cyclopentylmethyl)-N-hydroxy-gamma-oxo-alpha-((3,4,4-trimethyl-2,5-dioxo-1-imidazolidin-yl)methyl)-1-piperidinebutanamide
  • (alphaR,betaR)-beta-(Cyclopentylmethyl)-N-hydroxy-gamma-oxo-alpha-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl]-1-piperidinebutanamide; Cipemastat; Ro 32-3555/000; Trocade; Ro 32-3555
  • 1-[3-cyclopentyl-2(R)-[1(R)-(hydroxycarbamoyl)-2-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)-ethyl]propionyl]piperidine
  • 1-[3-cyclopentyl-2(R)-[1(R)-(hydroxycarbamoyl)-2-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)ethyl]propionyl]piperdine
  • 1-[3-cyclopentyl-2(R)-[1(R)-(hydroxycarbamoyl)-2-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)ethyl]propionyl]piperidine
  • 1-[3-cyclopentyl-2(R)[1(R)-(hydroxycarbamoyl)-2-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)ethyl]propionyl]piperidine
  • 1-PIPERIDINEBUTANAMIDE, .BETA.-(CYCLOPENTYLMETHYL)-N-HYDROXY-.GAMMA.-OXO-.ALPHA.-((3,4,4-TRIMETHYL-2,5-DIOXO-1-IMIDAZOLIDINYL)METHYL)-, (R-(R*,R*))-
  • 1-Piperidinebutanamide, .beta.-(cyclopentylmethyl)-N-hydroxy-.gamma.-oxo-.alpha.-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl]-, (.alpha.R,.beta.R)-
  • 1-Piperidinebutanamide, |A-(cyclopentylmethyl)-N-hydroxy-|A-oxo-|A-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl]-, (|AR,|AR)-
  • 1-Piperidinebutanamide, beta-(cyclopentylmethyl)-N-hydroxy--oxo-a-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl]-, (aR,betaR)-
  • 1-Piperidinebutanamide, beta-(cyclopentylmethyl)-N-hydroxy-gama-oxo-alpha-((3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl)-, (R-(R*,R*))-
  • N-hydroxy(2R,3R)-3-(cyclopentylmethyl)-4-oxo-4-(piperidin-1-yl)-2-[(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl]butanimidic acid